Induction of autoimmune cholangitis in non-obese diabetic (NOD).1101 mice following a chemical xenobiotic immunization.
about
Adaptive immunity in the liverXenobiotics and loss of tolerance in primary biliary cholangitisPrimary biliary cirrhosis: From bench to bedsideThe immunogenetics of primary biliary cirrhosis: A comprehensive reviewThe genetics of complex cholestatic disordersLiver immunology.The autoimmunity of primary biliary cirrhosis and the clonal selection theory.Environmental factors in primary biliary cirrhosis.B cell depletion therapy exacerbates murine primary biliary cirrhosisToxicology of autoimmune diseases.E. coli Induced Experimental Model of Primary Biliary Cirrhosis: At Last.Immune-mediated bile duct injury: The case of primary biliary cirrhosis.Pathological features of new animal models for primary biliary cirrhosis.Genome-Wide Association Studies in Primary Biliary Cirrhosis.Therapeutic effect of cytotoxic T lymphocyte antigen 4/immunoglobulin on a murine model of primary biliary cirrhosisA contemporary perspective on the molecular characteristics of mitochondrial autoantigens and diagnosis in primary biliary cholangitis.Deletion of interleukin-12p40 suppresses autoimmune cholangitis in dominant negative transforming growth factor beta receptor type II mice.Experimental evidence on the immunopathogenesis of primary biliary cirrhosis.Immunological orchestration of liver fibrosis.Autoimmune features in metabolic liver disease: a single-center experience and review of the literature.Animal models in primary biliary cirrhosis and primary sclerosing cholangitis.Etiopathogenesis of primary biliary cirrhosis: an overview of recent developments.It is time to change primary biliary cirrhosis (PBC): New nomenclature from "cirrhosis" to "cholangitis", and upcoming treatment based on unveiling pathology.Electrophile-modified lipoic derivatives of PDC-E2 elicits anti-mitochondrial antibody reactivity.Endogenous interleukin-22 protects against inflammatory bowel disease but not autoimmune cholangitis in dominant negative form of transforming growth factor beta receptor type II mice.Animal models of primary biliary cirrhosis.Epigenetics in the Primary Biliary Cholangitis and Primary Sclerosing Cholangitis.The multi-hit hypothesis of primary biliary cirrhosis: polyinosinic-polycytidylic acid (poly I:C) and murine autoimmune cholangitis.From pathogenesis to novel therapies in the treatment of primary biliary cholangitis.The induction of autoimmune hepatitis in the human leucocyte antigen-DR4 non-obese diabetic mice autoimmune hepatitis mouse model.Identification of a xenobiotic as a potential environmental trigger in primary biliary cholangitis
P2860
Q26753195-85B13FA8-7F16-4123-9214-09FDB282C84EQ26772312-7BC1D312-8E21-455C-A5D4-F8F6AC3BF23CQ26799419-85C6773C-43DE-42C7-9E8A-3DF16CEE5731Q26801377-DDDB7706-9508-41C5-8342-FD53B589B615Q26992279-E9EABC8D-0910-4457-BEDF-9282E99CB052Q34359990-44549DC8-2331-4EE2-BB7F-1CA8AA2E266DQ34472336-0EB3E590-BAF4-4ABC-B2BF-59E8FF116025Q34513032-14A9A8A3-60E5-46AB-8E04-D9984F0592F7Q34678839-761A0E20-DAA3-4717-9257-30BAD285AF32Q34788943-EFB0467B-B46D-47AC-B159-D63965E17C3AQ34793579-87AC515E-46EC-4302-877F-3DE8ED95BB25Q34992359-0B376A45-D8AE-4828-8587-DF5CEA67CC93Q35203353-B4E4DF5E-FA4A-4F80-833A-AD74490A15C6Q36383011-CCBB1C72-A738-4551-8F8D-AD619817B220Q36542397-4EF8F1F2-37D0-45DF-A6D9-1A3F74872964Q37135580-7E918705-7C37-4FE8-89CD-5B7DD7EA5E43Q37438364-6EC7C3D2-0DC6-432E-8FC8-A3034C3546A7Q37661371-B12E6410-D9C5-4008-A1C5-987CDAC6018FQ38018539-27A0C7EE-754F-46D3-91EA-C329D0CC3096Q38120662-08A428F1-6B75-484E-B237-DBBDE27BB0E9Q38244716-F01EC050-C58C-432D-9E7A-8207A3E33FB9Q38552201-C76CA088-5AE1-45D2-9FF3-9E22AFBF4EBEQ38620686-B0019EDB-D236-44AD-B07B-8DF2393A837FQ38905591-B1E22E3C-33FE-4B77-8BF2-3FA4000A899EQ39792098-E50A150F-2C42-46FB-9814-752D90E1F530Q41221983-6CA6A0F5-55E3-4577-B292-742E7045B711Q41361892-6583DC4A-0B4E-454D-BAB2-B6F3E6ECE147Q43785645-32D5CB68-9ED5-4B14-9E13-04D4411F5BA0Q46135644-86F5AB9C-0532-4E2B-8B7C-9741B2E3D28BQ49036478-3A442207-CFB2-42F2-B58D-8EDB28BDCF3CQ58702534-A8C7D3B7-5D83-48B1-A6F7-29E37C1BA3C3
P2860
Induction of autoimmune cholangitis in non-obese diabetic (NOD).1101 mice following a chemical xenobiotic immunization.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Induction of autoimmune cholan ...... mical xenobiotic immunization.
@en
Induction of autoimmune cholangitis in non-obese diabetic
@nl
type
label
Induction of autoimmune cholan ...... mical xenobiotic immunization.
@en
Induction of autoimmune cholangitis in non-obese diabetic
@nl
prefLabel
Induction of autoimmune cholan ...... mical xenobiotic immunization.
@en
Induction of autoimmune cholangitis in non-obese diabetic
@nl
P2093
P2860
P921
P1476
Induction of autoimmune cholan ...... mical xenobiotic immunization.
@en
P2093
A A Ansari
I R Mackay
K Tsuneyama
K Wakabayashi
L S Wicker
P S C Leung
W M Ridgway
P2860
P304
P356
10.1111/J.1365-2249.2008.03837.X
P577
2008-12-15T00:00:00Z